Literature DB >> 2306384

Myasthenia gravis: effect of thymectomy in 425 patients. A 15-year experience.

J Molnár1, A Szobor.   

Abstract

We report 425 myasthenic patients who underwent thymectomy during the last 15 years. The authors analyse the results of thymectomy in separate groups, including thymomas (12.7%), childhood myasthenia (9.4%) and combined cases (12.4%). They evaluate the results according to the Disability Status Scale based on a points system. Three series were evaluated: patients operated upon between 1972-1977, 1977-1982 and 1982-1987. Although the results in all three series were good, there has been steady improvement over the years. Childhood myasthenia gravis gave the best results but thymectomy was beneficial in the combined (immunological) group, in long-lasting myasthenia and in thymomas. Factors influencing the results of thymectomy were patients' age, time interval between onset of disease and thymectomy, resistence to therapy and thymic tumour. Thymic activity as reflected in germinal centres can also influence the results: the more active the thymus, the better the results.

Entities:  

Mesh:

Year:  1990        PMID: 2306384     DOI: 10.1016/1010-7940(90)90233-p

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Thymectomy for myasthenia gravis.

Authors:  J D Urschel; R P Grewal
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

2.  Influence of human myasthenia gravis thymus on the differentiation of human cord blood stem cells in SCID mice.

Authors:  Qian Ru Li; Ping Ping Liu; Xiao Yan Xuan; Sha Sha Guan; Ying Du; Feng Gao; Qing Yong Zhang
Journal:  Neurol Sci       Date:  2013-06-27       Impact factor: 3.307

Review 3.  Long-term outcome and quality of life after thymectomy for myasthenia gravis.

Authors:  C Busch; A Machens; U Pichlmeier; T Emskötter; J R Izbicki
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

4.  Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.

Authors:  Florence Jambou; Wei Zhang; Monique Menestrier; Isabelle Klingel-Schmitt; Olivier Michel; Sophie Caillat-Zucman; Abderrahim Aissaoui; Ludovic Landemarre; Sonia Berrih-Aknin; Sylvia Cohen-Kaminsky
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

5.  Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

Authors:  Anna Balandina; Sandrine Lécart; Philippe Dartevelle; Abdelhadi Saoudi; Sonia Berrih-Aknin
Journal:  Blood       Date:  2004-09-28       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.